Oaktree Acquisition Corp. III Life Sciences: what insiders have been doing
We have very little insider data for Oaktree Acquisition Corp. III Life Sciences so far: the most recent filing dates from 23 October 2026. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 4,798,758 sharesClass A Ordinary SharesSEC:0001193125-26-430503:0
- 33,981 shares@ US$10.00100.0% of flowClass A ordinary sharesSEC:0000950170-24-119552:0
2 of 2 declarations
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences is a special purpose acquisition company focused on the life sciences sector. It aims to identify and acquire innovative companies in this field.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
